General Discussion, page-10772

A few important points that our resident antagonists may have glossed over;

• Ganfeng are the sole 'buyer' of SC produced by Goulamina for stage 1. All product goes to their own downstream chemical plant for value add. Market prices for SC6 are more or less irrelevant other than factoring in taxes and royalties payable to Mali.
• As far as what SC price would be uneconomical.... I would guess that provided the sale price of hydroxide / carbonate from their plant exceeds the production costs, Goulamina is economical for Ganfeng.
• Given taxes / royalties payable to Mali are likely based at least in part on the prevailing SC6 market rates, the lower the market price for SC6, the lower the overall cost to Ganfeng.
• Personally, I would think that if SC6 market prices continue to drop, Ganfeng would want to bring forward T2 payment rather than continuing to incur interest on the debt.